Security key
955306105
WEST PHARMACEUTICAL SERVICES INC - COMMON STOCK (WST)
CUSIP: 955306105
Q2 2022 13F Holders as of 30 Jun 2022
- Security type / class
- Equity / COMMON STOCK
- Total 13F shares
- 68,252,580
- Total 13F value
- $20,598,288,583
- Share change
- -854,932
- Put/Call ratio
- 47%
- SEC-reported price per share
- $302.37
- Number of holders
- 645
- Value change
- -$313,220,081
- Number of buys
- 276
- Number of sells
- 377
- Shares outstanding
- 71,180,316
Holder snapshot
7 signals
Open additional details 1 more signal available
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q2 2022
Institutions
645
Top holders
10
WST full security history
Ownership snapshot
Full 13F holder table
WEST PHARMACEUTICAL SERVICES INC SEC filings
WEST PHARMACEUTICAL SERVICES INC company facts
Broader feeds
Ownership snapshot
Top reported holders of WST - WEST PHARMACEUTICAL SERVICES INC - COMMON STOCK (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
VANGUARD GROUP INC
Disclosed value leader
VANGUARD GROUP INC
Comparable rows
0/15
Latest evidence
31 Mar 2022
13F
Highest disclosed value: $3,579,876,000
15 rows are not safely comparable across share classes.
Showing 1-6 of 15 holder rows.
Quick read
VANGUARD GROUP INC has the largest disclosed position value at $3.58B.
0 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens VANGUARD GROUP INC's linked filing trail.
Disclosed position value
Top 5
VANGUARD GROUP INC
$3.58B
BlackRock Finance, Inc.
$3.32B
PRICE T ROWE ASSOCIATES INC /MD/
$2.62B
STATE STREET CORP
$1.39B
FRANKLIN TEMPLETON INC
$1.15B
Value bars compare disclosed positions; verify each figure against the linked filing evidence.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| VANGUARD GROUP INC |
13F
Company
|
—
denominator unverified
|
$3,579,876,000
8,716,312 shares
|
— | 31 Mar 2022 |
| BlackRock Finance, Inc. |
13F
Company
|
—
denominator unverified
|
$3,319,253,000
8,081,739 shares
|
— | 31 Mar 2022 |
| PRICE T ROWE ASSOCIATES INC /MD/ |
13F
Company
|
—
denominator unverified
|
$2,620,764,000
6,381,058 shares
|
— | 31 Mar 2022 |
| STATE STREET CORP |
13F
Company
|
—
denominator unverified
|
$1,393,912,000
3,393,907 shares
|
— | 31 Mar 2022 |
| FRANKLIN TEMPLETON INC |
13F
Company
|
—
denominator unverified
|
$1,152,034,000
2,804,979 shares
|
— | 31 Mar 2022 |
| APG Asset Management N.V. |
13F
Company
|
—
denominator unverified
|
$937,277,000
2,539,168 shares
|
— | 31 Mar 2022 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q2 2022
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
645
Shares
68,252,580
Rows available
645
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q2 2022 vs Q1 2022 Across Filers
Q1 2022 holders
703
Q2 2022 holders
645
Holder diff
-58
| Investor | Q1 2022 Shares | Q2 2022 Shares | Share Diff | Share Chg % | Q1 2022 value | Q2 2022 value | Value change | Value Chg % |
|---|